Effect of oral isotritinion on sexual function and desire in males with acne vulgaris: a cross sectional randomized study

Effect of oral isotritinion on sexual function and desire in males with acne vulgaris: a cross sectional randomized study - Effect of oral isotritinion on sexual function and desire in males with acne vulgaris: a cross sectional randomized study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000054398

Enrollment

120

Registered

2024-05-16

Start date

2024-05-24

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acne vulgaris and male sexual dysfunction

Interventions

Group 1: normal males not receiving isotretinion (control group) Group 2: male patient receiving isotretinion for 2 months. Group 3: male patient receiving isotretinion for 4 months Group 4: male pat

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: Males with severe nodulocystic acne

Exclusion criteria

Exclusion criteria: Any male with systemic illnesses or receiving medication causing erectile dysfunction or affecting his desire

Design outcomes

Primary

Measure	Time frame
To identify the presence of sexual dysfunction in male patients receiving isotretinion for treatment of acne vulgaris. Assessment of the severity of acne.	—

Secondary

Measure	Time frame
To evaluate relationship of male sexual dysfunction & symptoms of anxiety and depression in males caused by acne vulgaris and isotretinion treatment. To evaluate the effect of isotretinion on male sexual desire	—

Countries

Africa

Contacts

Public ContactSameh GamalEl Din

Cairo University Andrology & STDs

samehfayek@kasralainy.edu.eg002025729584

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026